Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
Christine Katlama, Robert MurphyPierre et Marie Curie Université – Paris 6, Service de Maladies Infectieuses et Tropicales, Paris, FranceAbstract: Integrase is an essential HIV-1-specific enzyme that is an active target for antiretroviral drug development. Recently, a ne...
Main Authors: | Christine Katlama, Robert Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-04-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/emerging-role-of-integrase-inhibitors-in-the-management-of-treatment-e-a3087 |
Similar Items
-
Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
by: Linda A. Mandikiyana Chirimuta, et al.
Published: (2022-10-01) -
Drug-selective pressure effect on HIV integrase mutations in antiretroviral naïve and experienced patients
by: Parya Basimi, et al.
Published: (2023-04-01) -
Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome
by: Pablo Villoslada-Blanco, et al.
Published: (2022-12-01) -
Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008-06-01) -
HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)